{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:57:04Z","timestamp":1790193424910,"version":"4.1.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T00:00:00Z","timestamp":1404950400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0101916","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T17:54:16Z","timestamp":1405014856000},"page":"e101916","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Meta-Analysis Assessment of GP210 and SP100 for the Diagnosis of Primary Biliary Cirrhosis"],"prefix":"10.1371","volume":"9","author":[{"given":"Shi-Ling","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Rong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Xian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,7,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"KD Lindor","year":"2009","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Muratori L, Granito A, Muratori P, Pappas G, Bianchi FB (2008) Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin Liver Dis 12: 261\u2013276; vii. doi: 10.1016\/j.cld.2008.02.009.","DOI":"10.1016\/j.cld.2008.02.009"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.3748\/wjg.v16.i29.3616","article-title":"Primary biliary cirrhosis: what do autoantibodies tell us?","volume":"16","author":"CJ Hu","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.cgh.2009.07.012","article-title":"Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease","volume":"7","author":"P Milkiewicz","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2004.11.016","article-title":"Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis","volume":"42","author":"M Nakamura","year":"2005","journal-title":"J Hepatol"},{"key":"ref6","first-page":"209","article-title":"Diagnostic significance of autoantibodies in patients with primary biliary cirrhosis","volume":"44","author":"H Xiao","year":"2012","journal-title":"Beijing Da Xue Xue Bao"},{"key":"ref7","first-page":"1478","article-title":"Detection of multicore point type antinuclear antibodies in primary biliary cirrhosis patients","volume":"13","author":"J Shao","year":"2005","journal-title":"World Chinese Journal of Digestology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-3083.1995.tb03652.x","article-title":"Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis","volume":"42","author":"T Sternsdorf","year":"1995","journal-title":"Scand J Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5387\/fms.58.107","article-title":"Autoantibodies by line immunoassay in patients with primary biliary cirrhosis","volume":"58","author":"H Saito","year":"2012","journal-title":"Fukushima J Med Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1572-0241.2003.07257.x","article-title":"Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis","volume":"98","author":"P Muratori","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/hep.21172","article-title":"Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis","volume":"43","author":"J Wesierska-Gadek","year":"2006","journal-title":"HEPATOLOGY"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"M Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1746.1998.01553.x","article-title":"Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis","volume":"13","author":"S Itoh","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"ref14","first-page":"132","article-title":"Clinical significance of serum anti-SP100 and anti-GP210 detection in diagnosis of patients with primary biliary cirrhosis","volume":"14","author":"YM Tang","year":"2011","journal-title":"J Clin Hepatol"},{"key":"ref15","first-page":"1303","article-title":"Value of detection of autoantibody in differential diagnosis of chronic cholestatic liver disease","volume":"11","author":"JX Lu","year":"2011","journal-title":"China Tropical Medicine"},{"key":"ref16","first-page":"256","article-title":"Detection of anti-SP100 and nuclear dots antibodies in patients with primary biliary cirrhosis","volume":"27","author":"Y Liu","year":"2009","journal-title":"Chines Journal of Clinical Laboratory Science"},{"key":"ref17","first-page":"17","article-title":"Study of specific autoantibodies in patients with primary biliary cirrhosis","volume":"52","author":"WH Peng","year":"2012","journal-title":"Shandong Medical Journal"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2249.2010.04288.x","article-title":"Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis","volume":"163","author":"LM Stinton","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"ref19","first-page":"892","article-title":"High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis. Mod Rheumatol","volume":"22","author":"S Imura-Kumada","year":"2012"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1007\/s10620-011-1756-1","article-title":"Prevalence of autoimmune liver disease related autoantibodies in Chinese patients with primary biliary cirrhosis","volume":"56","author":"C Hu","year":"2011","journal-title":"Dig Dis Sci"},{"key":"ref21","first-page":"2250","article-title":"Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol","volume":"36","author":"S Assassi","year":"2009"},{"key":"ref22","first-page":"19","article-title":"Diagnostic value of a variety of autoantibodies detection in patients with primary biliary cirrhosis","volume":"5","author":"HH Du","year":"2013","journal-title":"Chinese Journal of Liver Diseases"},{"key":"ref23","first-page":"55","article-title":"Diagnostic value of gp210 and sp100 antibodies in patients with primary biliary cirrhosis","volume":"22","author":"J Wu","year":"2012","journal-title":"China Journal of Modern Medicine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1590-8658(03)00466-3","article-title":"Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection","volume":"35","author":"DP Bogdanos","year":"2003","journal-title":"Dig Liver Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ajg.2009.596","article-title":"PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis","volume":"105","author":"A Granito","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"ref26","first-page":"495","article-title":"Detection of Gp210 Autoantibodies in Primary Biliary Cirrhosis Using a Recombinant Protein Containing the Predominant Autoepitope","volume":"21","author":"F Tartakovsky","year":"1995","journal-title":"Hepatology"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Szostecki C, Guldner HH, Netter HJ, Will H (1990) Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J Immunol 145: 4338\u20134347. [PubMed, PMID: 2258622].","DOI":"10.4049\/jimmunol.145.12.4338"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.510230512","article-title":"Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis","volume":"23","author":"O Bandin","year":"1996","journal-title":"Hepatology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1478-3231.1999.tb00021.x","article-title":"Autoimmune cholangitis and primary biliary cirrhosis-an autoimmune enigma","volume":"19","author":"H Kinoshita","year":"1999","journal-title":"Liver"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/HAB-1996-7404","article-title":"Anti-gp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64 kD fragment of gp210 as a major epitope","volume":"7","author":"J Wesierska-Gadek","year":"1996","journal-title":"Hum Antibodies Hybridomas"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0896-8411(03)00033-7","article-title":"Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study","volume":"20","author":"K Miyachi","year":"2003","journal-title":"J Autoimmun"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jcla.20170","article-title":"Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis","volume":"21","author":"A Bauer","year":"2007","journal-title":"J Clin Lab Anal"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-008-0150-6","article-title":"The value of antinuclear antibodies in primary biliary cirrhosis","volume":"8","author":"L Gao","year":"2008","journal-title":"Clin Exp Med"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Nickowitz RE, Wozniak RW, Schaffner F, Worman HJ (1994) Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. Gastroenterology 106: 193\u2013199. [PubMed, PMID: 8276182].","DOI":"10.1016\/S0016-5085(94)95333-3"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.1840080438","article-title":"Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis","volume":"8","author":"F Lozano","year":"1988","journal-title":"Hepatology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-3-25","article-title":"The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews","volume":"3","author":"P Whiting","year":"2003","journal-title":"BMC Med Res Methodol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-1596-4-1","article-title":"Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited","volume":"4","author":"Y Kumar","year":"2009","journal-title":"Diagn Pathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5858\/2000-124-0071-GFCUOT","article-title":"Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists","volume":"124","author":"A Kavanaugh","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, <etal>et al<\/etal>.. (2002) Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 117: 316\u2013324. [PubMed, PMID: 11863229].","DOI":"10.1309\/Y5VF-C3DM-L8XV-U053"},{"key":"ref40","unstructured":"Scagliusi P, De Lucia M, Di Luca ML, Pannarale M, Pipitone V (1984) Clinical significance of antinuclear antibodies in progressive systemic sclerosis. Minerva Med 75: 161\u2013166. [PubMed, PMID: 6366619]."},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Walker JG, Doniach D, Roitt IM, Sherlock S (1965) Serological tests in diagnosis of primary biliary cirrhosis. Lancet 1: 827\u2013831. [PubMed, PMID: 14263538].","DOI":"10.1016\/S0140-6736(65)91372-3"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1568-9972(03)00013-2","article-title":"Antinuclear antibodies specific for primary biliary cirrhosis","volume":"2","author":"HJ Worman","year":"2003","journal-title":"Autoimmun Rev"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-2005-916321","article-title":"Antinuclear antibodies in primary biliary cirrhosis","volume":"25","author":"P Invernizzi","year":"2005","journal-title":"Semin Liver Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"MM Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/ard.60.11.1046","article-title":"Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients","volume":"60","author":"B Marasini","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/qjmed\/hch078","article-title":"Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study","volume":"97","author":"FE Watt","year":"2004","journal-title":"QJM"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2188\/jea.15.24","article-title":"A cross-sectional study of primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid","volume":"15","author":"F Sakauchi","year":"2005","journal-title":"J Epidemiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM198905253202104","article-title":"Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis","volume":"320","author":"J van de Water","year":"1989","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Hu SL, Zhao FR, Wang QS, Chen WX (2014) The accuracy of the anti-mitochondrial antibody and the M2 subtype test for diagnosis of primary biliary cirrhosis: a meta-analysis. Clin Chem Lab Med. doi: 10.1515\/cclm-2013-0926. [Epub ahead of print].","DOI":"10.1515\/cclm-2013-0926"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1083\/jcb.108.6.2083","article-title":"Primary structure analysis of an integral membrane glycoprotein of the nuclear pore","volume":"108","author":"RW Wozniak","year":"1989","journal-title":"J Cell Biol"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Greber UF, Senior A, Gerace L (1990) A major glycoprotein of the nuclear pore complex is a membranespanning polypeptide with a large lumenal domain and a small cytoplasmic tail. EMBO J 9: 1495\u20131502. [PubMed, PMID: 2184032].","DOI":"10.1002\/j.1460-2075.1990.tb08267.x"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaut.2010.09.005","article-title":"PBC screen: an IgG\/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis","volume":"35","author":"H Liu","year":"2010","journal-title":"J Autoimmun"},{"key":"ref53","first-page":"1123","article-title":"Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis","volume":"26","author":"D Zuchner","year":"1997","journal-title":"HEPATOLOGY"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0348620","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0101916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T04:56:01Z","timestamp":1689396961000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0101916"}},"subtitle":[],"editor":[{"given":"Robert Lane","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,10]]},"references-count":53,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0101916","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,10]]}}}